文献速递儿童消化与营养新生儿儿童内分泌与遗传代谢

DCDC2基因变异致同胞新生儿硬化性胆管炎两例并文献复习

[Neonatal sclerosing cholangitis caused by DCDC2 variations in two siblings and literature review].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2018-01-01

该研究对复旦大学附属儿科医院2017年5月诊断的2例DCDC2基因变异致新生儿硬化性胆管炎同胞进行全外显子组测序和临床总结,并检索至2018年4月的文献复习共13例患儿。结论指出该病以婴儿期高γ-谷氨酰转肽酶胆汁淤积伴陶土样便为特征,常进展为肝硬化,确诊依靠DCDC2基因检测。

要点

  • DCDC2相关NSC在生后6个月内发病,表现为高GGT胆汁淤积和陶土样便,可进展至门静脉高压和肝硬化。
  • 胆道造影或MRCP显示肝内和(或)肝外胆管多灶性狭窄或扩张,常伴肾脏和神经系统异常。
  • 确诊依靠DCDC2基因检测,13例中10例需肝移植,共检测到7种DCDC2变异。

核心结论

  • DCDC2基因变异致NSC以婴儿期高γ-谷氨酰转肽酶胆汁淤积伴陶土样便为特征,常在儿童期进展为肝硬化,确诊依靠DCDC2基因检测。

研究设计与样本

  • 对复旦大学附属儿科医院2017年5月诊断的2例DCDC2变异致NSC同胞进行全外显子组测序和临床遗传学总结。
  • 检索建库至2018年4月的中文数据库及PubMed,以DCDC2和新生儿硬化性胆管炎为关键词进行文献复习。

主要发现

  • 例1为3岁2月龄男童,胆汁淤积3年余,GGT 161~1 092 U/L,总胆固醇5.4~7.7 mmol/L,MRCP示肝内胆管多发扩张和双肾积水。
  • 例2为9岁9月龄男童(例1同胞兄长),胆汁淤积9年余,CT血管造影示脑积水和左侧颈内动脉交通段动脉瘤并有血管畸形。
  • 例1检出DCDC2基因c.529dupA纯合移码变异,例2该位点为纯合变异,父母均为杂合变异。
  • 文献复习共13例患儿均在生后6个月内发病,最常见表现为高GGT胆汁淤积伴陶土样便并进展至门静脉高压,其次为肾脏和神经系统表型。
  • 13例中10例需要肝移植,共检测到7种DCDC2基因变异。

关键数值与推荐

  • 13例患儿均在生后6个月内发病。
  • 例1 GGT 161~1 092 U/L,总胆固醇5.4~7.7 mmol/L。
  • 13例中10例需要肝移植,共检测到7种DCDC2基因变异。
  • 影像学特征为肝内和(或)肝外胆管多灶性狭窄或扩张。

临床怎么用

  • 对婴儿期出现高GGT胆汁淤积伴陶土样便的患儿,应警惕DCDC2相关NSC并行基因检测以确诊。
  • 确诊或疑似病例应评估肾脏和神经系统异常,并监测门静脉高压和肝硬化进展。

局限性

  • 文献复习仅检索到英文文献2篇、中文文献0篇,共11例,样本量小。
  • 研究为病例总结和文献复习,未报告长期随访和治疗对照数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To summarize and review the clinical and genetic features of neonatal sclerosing cholangitis (NSC) caused by DCDC2 variations. Methods: Whole exome sequencing was performed to identify DCDC2 variants in two Chinese siblings with NSC who were diagnosed in Children's Hospital of Fudan University in May 2017. Clinical, laboratory and genetic data of the two cases were summarized. Key words of "DCDC2" "neonatal sclerosing cholangitis" were searched in Chinese databases and PubMed for articles published until April 2018, and all the relevant literature were reviewed. Results: Patient 1 was a 3-year-and-2-month-old boy. He was admitted to our hospital due to cholestasis for 3 years. Laboratory findings showed elevated levels of gamma-glutamyl transpeptidase (161-1 092 U/L) and total cholesterol (5.4-7.7 mmol/L). Magnetic resonance cholangiopancreatography showed multiple dilations of intrahepatic bile ducts and bilateral hydronephrosis. Patient 2, the older brother of patient 1, was a 9-year-and-9-month-old boy. He was admitted to our hospital due to "cholestasis for 9 years" . CT angiography showed hydrocephalus and left internal carotid artery aneurysms with vascular malformations. A homozygous variant c.529dupA (NM_001195610) in DCDC2 gene was identified in patient 1 by whole exome sequencing. Patient 2 was a homozygote and his parents were heterozygotes with the variation. There has been 2 relevant articles published (Chinese 0, English 2), which reported 11 cases of DCDC2-related NSC in total. All the 13 patients, including the 2 cases reported here, had an onset of symptoms at 0 to 6 months of age. The most common clinical manifestation was cholestasis with high gamma-glutamyl transpeptidase levels, acholic stool, and progression to portal hypertension. Renal and neurological abnormalities were also frequently present. Hypercholesterolemia was observed in one case. Radiological findings revealed the characteristic strictures and dilatations of the intrahepatic and (or) extrahepatic biliary tree. Liver histological examination showed peripheral ductopenia, ductal plate malformation, fibrosis, and cirrhosis. Among the 13 patients, 10 patients required liver transplantation. A total of 7 types of DCDC2 variants were detected in 13 patients. Conclusions: DCDC2-related NSC is characterized by the onset of cholestasis with high gamma-glutamyl transpeptidase level and acholic stool in early infancy, which was likely to progress to cirrhosis in early childhood. Renal and neurological abnormalities are also frequently present.Cholangiography or magnetic resonance cholangiopancreatography show strictures and dilatations of the intrahepatic or (and) extrahepatic biliary tree. Identification of pathogenic DCDC2 variants would aid the diagnosis of NSC. 目的: 总结DCDC2基因变异引起的新生儿硬化性胆管炎(NSC)的临床及遗传学特点。 方法: 采用全外显子组测序技术,复旦大学附属儿科医院在2017年5月明确诊断了来自同一家系的2例DCDC2缺陷致NSC患儿,对其临床特征和基因结果进行总结,并以"DCDC2"和"新生儿硬化性胆管炎"为关键词,检索建库至2018年4月中文数据库及PUBMED数据库进行文献复习。 结果: 例1男,3岁2月龄,发现胆汁淤积3年余,血清γ-谷氨酰转肽酶(161~1 092 U/L)和总胆固醇(5.4~7.7 mmol/L)升高,磁共振胰胆管造影示肝内胆管多发扩张和双肾积水。例2男,9岁9月龄,是例1的同胞兄长。发现胆汁淤积9年余,CT血管造影示脑积水和左侧颈内动脉交通段动脉瘤并有血管畸形。例1通过全外显子组测序发现DCDC2基因(NM_001195610)c.529dupA纯合移码变异。通过Sanger测序发现例2在该位点为纯合变异,父母均为杂合变异。共检索到英文文献2篇,中文文献0篇,11例DCDC2基因变异致NSC患儿。包括本研究2例共计13例患儿均在生后6个月之内发病,最常见的临床表现有高水平γ-谷氨酰转肽酶的胆汁淤积伴陶土样便,进展至门静脉高压;其次是肾脏和神经系统表型;仅有1例患儿有高胆固醇血症;影像学特征为肝内和(或)肝外胆管多灶性狭窄或扩张;肝脏病理表现为胆管板形成障碍、小叶间胆管缺乏、纤维化以及肝硬化等;13例患儿中有10例需要肝移植治疗。13例患儿中共检测到7种DCDC2基因变异。 结论: DCDC2基因变异致NSC临床特征为:婴儿期出现高水平γ-谷氨酰转肽酶的胆汁淤积伴陶土样便,常在儿童期进展为肝硬化;胆道造影或磁共振胰胆管造影显示肝内和(或)肝外胆管多灶性狭窄;常伴有肾脏和神经系统表型。确诊依靠DCDC2基因检测。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li JQ, Lu Y, Qiu YL, et al. [Neonatal sclerosing cholangitis caused by DCDC2 variations in two siblings and literature review]. Zhonghua Er Ke Za Zhi. 2018. PMID: 30078246. doi:10.3760/cma.j.issn.0578-1310.2018.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。